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ABSTRACT 
 
Coronavirus Disease-2019 (COVID-19) infection is suspected to affect sexual behavior and function 
of sexual. COVID-19 can cause penile vascular damage that leads to erectile dysfunction (ED). This 
problem is one of the most common sexual problems in men, with a percentage of 13-28% at the age 
of 40-80 years and the incidence increases with age. Currently, there is no data on the effect of COVID-
19 on sexual behavior. There was one case of COVID-19 with erectile dysfunction treated at COVID-
19 Emergency Hospital, Kemayoran Athlete Village. Erectile dysfunction is influenced by several 
factors, including psychogenic and neurogenic factors and infection. The diagnosis of erectile 
dysfunction was determined based on history taking and physical examination using the standard 
questionnaire (IIEF-5/International index of erectile function-5). A further study is needed to exclude 
a particular cause and the management of erectile dysfunction, which can be determined based on the 
etiology. 
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INTRODUCTION 
Erectile dysfunction occurs due to the 
sexual response blockage on the spinal nerve 
that is mediated by the neurotransmitter 
serotonin. Therefore, it is failed to initiate 
(neurogenic, psychogenic, endocrinologic), 
fill (atherogenic), accommodate, or maintain 
(corporal Veno-occlusive dysfunction) 
penetrating erection and erectile relaxation 
(priapism).1 Erectile dysfunction occurs in 
men with a percentage of 13-28% at the age 
of 40-80 years. Several etiologies are stated as 
the cause of erectile dysfunction, such as 
vasculogenic, psychogenic, and neurogenic 
factors, as well as infection. This case rarely 
takes place and is rarely published. On the 
other hand, the pathophysiology of erectile 
dysfunction can develop through numerous 
mechanisms. Therefore, this case report is 
organized by presenting some hypotheses 
regarding erectile dysfunction in a COVID-19 
patient.  
 
CASE ILLUSTRATION 
A 55-year-old man complained of 
anosmia 13 days before being treated at 
COVID-19 Emergency Hospital, Kemayoran 
Athlete Village, Jakarta. When the patient 
woke up, he experienced anosmia, followed 
by the inability to erect. The result from 
physical examination showed that his vital 
signs and general status were normal. It was 
found that the cremasteric reflex was positive 
from the local status examination. The result 
of COVID-19 RT-PCR (Reverse-
Transcriptase Polymerase Chain Reaction) 
was positive. Total blood examination and 
blood chemical profile, such as total 
cholesterol level, triglyceride, and fasting 
blood glucose, were found to be at normal 
rates. The patient got first-line COVID-19 
therapy in accordance with COVID-19 
protocol consisted of Azithromycin 1x500mg 
for five days, Oseltamivir 2x75mg for seven 
days, Zinc 1x20mg, as well as micronutrient 
supplements containing Vit B1 of 15 mg, Vit 
                                          Jurnal Profesi Medika : Jurnal Kedokteran dan                             
ISSN 0216-3438 (Print). ISSN 2621-1122 (Online)                                                                                               Kesehatan 
 
 
 
Vol. 15 No 1 2021 DOI: http://dx.doi.org/10.33533/jpm.v15i1.2715    102 
B2 of 10 mg, Vit B6 of 5 mg, Ca Pantothenate 
of 20 mg, and Nicotinamide of 50mg 2x1 a 
day. During the treatment, the patient was 
unable to erect and fall asleep. The patient was 
admitted for worrying about his condition and 
longing for the family. The patient received 
Clozapine 1x12.5 mg therapy. Within the 
observation, the patient’s sleep habit was 
getting better. After getting treatment for 24 
days, the patient was able to erect when 
waking up in the morning. The anosmia was 
getting better as well. The patient was finally 
able to move and socialize. Later, a swab test 
was once again done after treatment, which 
resulted in a negative RT-PCR so that the 
patient could be discharged.  
 
DISCUSSION 
Erectile dysfunction is the inability to 
maintain erectile function in achieving 
satisfying sexual activity.2 Erectile 
dysfunction diagnosis is established 
comprehensively, not only based on specific 
events.3 After the patient was found to 
experience erectile dysfunction symptoms, in-
depth anamnesis was done regarding other 
histories, chronic diseases, certain drug usage, 
or psychosocial problems. In this case, the 
erectile dysfunction diagnosis was made 
based on the International Index of Erectile 
Function-5 (IIEF-5), which resulted in a score 
of 11, which means moderate dysfunction. 
Erectile dysfunction occurs due to neurologic, 
endocrine, arthritogenic, venogenic, 
psychogenic, pharmacogenic, or iatrogenic 
abnormalities.1 Therefore, physical and 
supporting examinations were needed to 
remove other etiologies, such as endocrine, 
metabolic, and cardiovascular diseases.  
Many cardiovascular disease risk 
factors, particularly age, lifestyle, obesity, 
smoking habit, hypercholesterolemia, 
metabolic syndrome, insulin resistance, 
hypertension, and diabetes mellitus, affect 
erectile dysfunction. Therefore, early 
evaluation of erectile dysfunction had to 
distinguish erectile dysfunction vasculogenic 
from other etiologies. Findings from the 
analyzed case were used to execute various 
possible etiologies that could happen. In this 
case, it was found that the patient was an adult 
without a smoking history who had a job as a 
tennis coach. Other disease factors such as 
metabolic syndrome and diabetes were also 
not found.  
Erectile dysfunction in general, basic 
pathophysiology, and cardiovascular disease 
were included in endothelial dysfunction, 
inflammation, and low testosterone level. 
Endothelial dysfunction develops due to the 
decrease in oxide nitrite synthesis and 
atherosclerosis that causes damage to blood 
flow that functions for erection. Erectile 
dysfunction associated with the calcification 
of the coronary arteries in the heart forms an 
atherosclerotic plaque that will be linked to 
cardiovascular disease.4,5 The occurrence of 
erectile dysfunction is correlated with 
endothelial function damage, specifically 
affecting the vasodilatory function of the 
brachial artery.7 The role of infection 
incidents can be considered, especially in the 
formation of atherosclerosis associated with 
erectile dysfunction and cardiovascular 
disease.6 
Other factors of psychogenic can be 
obtained when there is sudden onset erectile 
dysfunction, decreased libido, and loss of 
erectile function in the morning.7 Psychogenic 
factors include worry, trauma due to sexual 
experience, loss of interest, and inadequate 
communication with a partner. In this case, it 
was found that the patient was worried about 
the health and family problems caused by 
COVID-19. 
Regarding sleep-related erection (SRE), 
erection can occur without stimulation when 
one is asleep, specifically when entering 
Rapid Eye Movement (REM) phase. Lateral 
Preoptic Area (LPOA) controls this 
mechanism, where lesions on bilateral 
preoptic area cause the absence of SRE.8 SRE 
is used to help the erectile dysfunction 
diagnosis as a result of psychogenic factor. 
Normal SRE is assumed to have a relation 
with normal erectile physiology. Meanwhile, 
on erectile dysfunction caused by other 
etiologies, SRE function is damaged. In this 
case, the patient’s inability to erect was also 
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found all the time, including when he was 
asleep and after waking up. 
With COVID-19 infection, erectile 
dysfunction, in this case, needs to be explored 
thoroughly. Coronavirus infection is related to 
neuropsychiatric disorder on Severe Acute 
Respiratory Syndrome (SARS) and Middle 
East Respiratory Syndrome (MERS). It was 
found that there is a direct infection on Central 
Nervous System (CNS) or indirect infection 
through the immune response mechanism.  
A study conducted by Desforges et al.14 
also show that coronavirus can cause 
psychiatric symptoms due to infiltration in the 
brain that can occur in SARS-CoV-2.11   In 
COVID-19 infection, cytokine storm is 
suspected to be involved in immune response 
related to neuroinflammation; where cytokine 
disturbance, especially IL-1B, IL-6, IL-10, 
IFN-y, TNF-a, and transforming growth 
factor-B (TGF-B) are related to the 
psychiatric disorder.12 Neuro disorder on 
SARS-CoV-2 infection like anosmia and 
ageusia causes a hypothesis that this infection 
is presumably spread to CNS.13 Other relevant 
studies also show that SARS-CoV-2 is present 
in the examination of Cerebrospinal Fluid 
(CSF).14 Further research is needed to find 
psychiatric disorders as the manifestation of 
CNS involvement in COVID-19 infection.  
In the patient, anosmia and erectile 
dysfunction symptoms were found 
simultaneously before the patient was 
infected with the SARS-CoV-2 virus. Overall, 
there was a neurologic symptom that often 
occurred to a patient with a COVID-19 
infection, in which anosmia can be found at 
the beginning of COVID-19. The SARS-
CoV-2 virus enters the cell through 
Angiotensin-Converting Enzyme-2 (ACE-2) 
receptor. Spike protein related to ACE-2 
receptor and can be completed with some 
protease enzymes (TMPRSS2 and furin) that 
are basically expressed by positive cells on 
ACE-2.15,16,17 There were receptors in the 
form of SARS-CoV-2 and coronavirus-
associated factors and receptors (SCARFs) 
which have roles in responding to virus ties 
with a system, specifically on sequencing or 
high throughput datasets.18 Anosmia 
symptom is based on ACE-2 expression on 
olfactory epithelium system .19 
A molecular mechanism that is able to 
explain neurological disorders requires more 
explanation by further research. There is a 
chance of dataset sorting process or 
sequencing from RNA causing ACE-2 to be 
expressed in dorsal root ganglion from a 
neurological disorder. A single-cell 
sequencing experiment from the dorsal root 
ganglion in mice has shown that there is a low 
neurologic expression of ACE-2 that also 
expresses Mrgprd and Nppb gen.20  MrgprD 
is a selective gene expressed by nociceptive 
structures in free nerve endings such as the 
skin, cornea, and luminal organs, namely 
bowels and meninges. 21,22,23 
According to Shiers et al., cellular 
expression of SARS-CoV-2 is associated with 
ACE-2 mRNA in nerve cells expressing 
calcitonin-gene-related peptide (CALCA) and 
P2X purigenic ion channel type 3 receptor 
gene (P2RX3).24 CALCA and P3RX3 genes 
are known to illustrate the subpopulation 
nociceptors in the dorsal root ganglion of 
mice. ACE-2 mRNA can be found in 19.8-
25.4% of the sensory nerve cells. The majority 
of ACE-2 expression can also be found in the 
nociceptive structure of a human’s dorsal root 
ganglion.25 
The occurrence of erectile is related to 
the innervation of the penis for both the 
autonomic nerve (sympathies and 
parasympathies) and somatic systems 
(sensory and motoric). Penile nerves originate 
from the spinal cord and peripheral ganglion. 
Sympathetic and parasympathetic nerves 
merge into cavernous nerves, which will 
innervate the corpora cavernosa, corpora 
spongiosa, causing vasodilatation and then 
erection. Somatic nerves are related to the 
process of musculus bulbocavernosus and 
ischiocavernosus contractions. Thus, an 
erection occurs.25 
Infection can affect the central nervous 
system, including neuropsychiatric disorders. 
One of the infection factors itself can also 
cause abnormality in the reproduction system 
that includes erectile dysfunction. The 
etiology factor of the infection that is directly 
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related to erectile dysfunction is assumed to 
appear. Virus infection, either directly or 
indirectly, can cause erectile dysfunction. It 
works directly on the inflammation process 
that is crucial to atherosclerosis formation. 
Virus infection causes an increase in 
inflammatory markers, such as CRP, IL-6, IL-
1b, TNF- α, intercellular adhesion molecules, 
and adhesion molecules on vascular cells that 
connect to erectile dysfunction.26,27 
COVID-19 infection is caused by the 
association between the dorsal root ganglion 
ACE-2 receptor with the virus itself, which 
then causes structural damage. This damage 
can irritate nerve stimulus function that is 
associated with erection on the sacral nerve 
segment. Therefore, there is a disturbance in 
pudendal nerves (S2-S4). Damage on the 
sacrum has a role in erectile dysfunction. 
Erectile dysfunction in COVID-19 patients 
also can be caused by the impairment of blood 
vessels in the penis. 28,29 
Based on this case report, further study 
is needed to determine factors that connect 
with reproduction system disorder, such as 
erectile dysfunction in virus infection, 
including COVID-19. The relationship 
between one etiology to another may also be 
found by an in-depth study.  
 
CONCLUSION 
Erectile dysfunction in COVID-19 
infection can be caused by many factors, 
including psychogenic factors and infection. 
Up to this moment, reports and scientific 
studies about COVID-19 are still limited. 
Therefore, controlling and further studies are 
required regarding the rise of erectile 
dysfunction. Therapy given to the patient is 
based on the COVID-19 therapeutic regimen 
that is still under further research. 
Psychologic, metabolic, vasculogenic, and 
other supporting factors have become 
important points to be considered as they play 
a role in predicting erectile dysfunction. 
Factors regarding erectile dysfunction in 
COVID-19 cannot be assessed from a certain 
side only. Consequently, further research is 
needed to answer the challenges and existed 
hypotheses.  
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